youtube_live
Q3 2026 earnings • in 1 day
See detailschevron_right
GERN:NASDAQ
Geron Corp
$0.93
arrow_upward
+3.88%(+0.035) 1D
$0.93
arrow_upward
+0.10% (+0.00090)todayPre-market
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GERN...
Open
$0.90
High
$0.93
Low
$0.88
Mkt. cap
599.87M
Avg. vol.
11.53M
Volume
5.07K
52-wk high
$2.01
52-wk low
$0.84
EPS
-$0.10
Beta
0.61
Shares outstanding
642.47M
No. of employees
258
Open
$0.90
High
$0.93
Low
$0.88
Mkt. cap
599.87M
Avg. vol.
11.53M
Volume
5.07K
52-wk high
$2.01
52-wk low
$0.84
EPS
-$0.10
Beta
0.61
Shares outstanding
642.47M
No. of employees
258
News stories
From web sources and news partners
Seeking Alpha
·
23 hours ago
Geron: Opportunity Builds Even As Struggles Continue (NASDAQ:GERN)
Profile
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
About Geron Corp
CEOJohn A Scarlett
Employees258
Founded1990
HeadquartersMenlo Park, California, United States
SectorBiotechnology
Websitegeron.com